Skip to content

GREEN VISION BIOTECHNOLOGY CORP.: 10-Q filed 2018-02-13

What GREEN VISION BIOTECHNOLOGY CORP. reported in its quarterly report filed 2018-02-13 (fiscal Q3 2017): 37 published measures, 108 facts as tagged in accession 0001640334-18-000282.

This filing

Form
10-Q (quarterly report)
Filed
2018-02-13
Fiscal period
fiscal Q3 2017
Accession
0001640334-18-000282 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GREEN VISION BIOTECHNOLOGY CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-09-305,171,633USD
At 2016-12-317,518,562USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2017-09-309,630,256USD
At 2016-12-3110,849,730USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-09-30-4,458,623USD
At 2016-12-31-3,331,168USD
At 2015-12-31-2,158,274USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-09-3059,532USD
At 2016-12-31518,849USD
At 2016-09-30256,595USD
At 2015-12-31469,556USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-603,678USD92
2017-01-01 to 2017-09-30-1,051,750USD273
2016-01-01 to 2016-12-31-1,049,897USD366
2016-07-01 to 2016-09-30-131,334USD92
2016-01-01 to 2016-09-30-488,738USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2017-01-01 to 2017-09-301,512USD273
2016-01-01 to 2016-09-301,450USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-09-30-4,251,700USD
At 2016-12-31-3,199,950USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2017-07-01 to 2017-09-30160,790,000shares92
2017-01-01 to 2017-09-30131,619,707shares273
2016-07-01 to 2016-09-30100,000,000shares92
2016-01-01 to 2016-09-30100,000,000shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2017-07-01 to 2017-09-30160,790,000shares92
2017-01-01 to 2017-09-30131,619,707shares273
2016-07-01 to 2016-09-30100,000,000shares92
2016-01-01 to 2016-09-30100,000,000shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-0.38USD/shares92
2017-01-01 to 2017-09-30-0.8USD/shares273
2016-07-01 to 2016-09-30-0.13USD/shares92
2016-01-01 to 2016-09-30-0.49USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-0.38USD/shares92
2017-01-01 to 2017-09-30-0.8USD/shares273
2016-07-01 to 2016-09-30-0.13USD/shares92
2016-01-01 to 2016-09-30-0.49USD/shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2017-07-01 to 2017-09-300USD92
2017-01-01 to 2017-09-300USD273
2016-07-01 to 2016-09-300USD92
2016-01-01 to 2016-09-300USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2017-09-303,072,163USD
At 2016-12-313,117,449USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-601,590USD92
2017-01-01 to 2017-09-30-1,047,123USD273
2016-07-01 to 2016-09-30-207,011USD92
2016-01-01 to 2016-09-30-550,546USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-09-301,194,481USD
At 2016-12-313,516,127USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-09-309,630,256USD
At 2016-12-3110,849,730USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2017-09-30126,971USD
At 2016-12-31146,222USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2017-09-30884,984USD
At 2016-12-31864,981USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2017-09-30443,356USD
At 2016-12-31791,800USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-07-01 to 2017-09-30607,369USD92
2017-01-01 to 2017-09-301,093,596USD273
2016-07-01 to 2016-09-30229,087USD92
2016-01-01 to 2016-09-30841,695USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2017-09-30273,991USD
At 2016-12-31231,976USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2017-07-01 to 2017-09-305,779USD92
2017-01-01 to 2017-09-3046,473USD273
2016-07-01 to 2016-09-3022,076USD92
2016-01-01 to 2016-09-30291,149USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-09-30160,790,000shares
At 2017-05-1260,790,000shares
At 2016-12-31100,000,000shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2017-09-30-85,504USD
At 2016-12-31-174,098USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2017-09-303,792,943USD
At 2016-12-313,631,922USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2017-09-30720,780USD
At 2016-12-31514,473USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2017-09-30884,984USD
At 2016-12-31864,981USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2017-09-3089,597USD
At 2016-12-31100,883USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-585,453USD92
2017-01-01 to 2017-09-30-963,156USD273
2016-01-01 to 2016-12-31-1,172,894USD366
2016-07-01 to 2016-09-30-181,931USD92
2016-01-01 to 2016-09-30-583,505USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2017-07-01 to 2017-09-30568,964USD92
2017-01-01 to 2017-09-301,041,981USD273
2016-07-01 to 2016-09-30214,650USD92
2016-01-01 to 2016-09-30777,447USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2017-07-01 to 2017-09-3060,207USD92
2017-01-01 to 2017-09-30179,474USD273
2016-07-01 to 2016-09-3061,065USD92
2016-01-01 to 2016-09-30190,408USD274

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2017-07-01 to 2017-09-306,009USD92
2017-01-01 to 2017-09-3017,922USD273
2016-07-01 to 2016-09-306,146USD92
2016-01-01 to 2016-09-3018,685USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-2,088USD92
2017-01-01 to 2017-09-30-4,627USD273
2016-07-01 to 2016-09-3075,677USD92
2016-01-01 to 2016-09-3061,808USD274

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2017-01-01 to 2017-09-300USD273
2016-01-01 to 2016-09-300USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-09-30-29,468USD273
2016-01-01 to 2016-09-30829,810USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-09-3031,035USD273
2016-01-01 to 2016-09-30-361,584USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-09-30-25,162USD273
2016-01-01 to 2016-09-3050,660USD274

Inspect the source

Entity
GREEN VISION BIOTECHNOLOGY CORP. / CIK 0001571804
Captured
SEC response SHA-256
f900c79f6de11454e9e92e93c55c93d276ffa598a95106526ff88cb826780ecf

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001571804.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))